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Adipose tissue engineering for breast reconstruction can be performed for patients 
who have undergone breast surgery. We have previously confirmed adipogenesis in 
mice implanted with type-I collagen sponge with controlled- release of fibroblast 
growth factor 2 (FGF2) and human adipose tissue-derived stem cells. However, in order 
to use this approach for treating breast cancer patients, FGF2 is not readily available 
and a large size of adipose tissue is needed. Herein, we aimed to regenerate large 
amounts of adipose tissue without FGF2 for a long period. Under general anesthesia, 
cages made of polypropylene mesh were implanted into the rabbits’ bilateral fat pad. 
The size of cage was 10 mm in radius and 10 mm in height. Minced type-I collagen 
sponge was injected as a scaffold into the cage. Regenerated tissue in the cage was 
examined with ultrasonography, and the cages were harvested 3, 6, and 12 months 
after the implantation. Ultrasonography revealed a gradually increasing homogenous 
high echo area in the cage. Histology of the specimen was assessed with 
hematoxylin-eosin staining. Percentages of regenerated adipose tissue area were 76.2 
± 13.0% and 92.8 ± 6.6% at 6 and 12 months after the implantation, respectively. Our 
results showed de novo adipogenesis 12 months after the implantation of only type-I 
collagen sponge inside the space. Ultrasonography is a non-invasive and useful method 
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to assess the growth of the tissue inside the cage. This simple method could be a 





Breast cancer is common disease among women worldwide. Breast surgery is not 
the best, but one of the local treatments of breast cancer since any defect of breast is 
distressing for patients. There are many ways for breast reconstruction, but each 
technique has its drawbacks. For example, silicone implants can induce foreign body 
response and be an obstacle during breast cancer screening. Autologous tissue graft 
implantation is a long surgical procedure, and results in operation scars at many sites. 
Autologous fat transfer has the drawbacks of shrinkage, fat necrosis or oil cyst 
formation [1]. Hence, adipose tissue engineering for breast reconstruction is a fourth 
alternative for patients who have undergone breast surgery.  
Previous study has confirmed adipogenesis in mice implanted with a type-I collagen 
sponge with controlled- release of FGF2 and human adipose tissue-derived stem cells 
(ASCs) [2]. We showed that human ASCs not only function as progenitor cells for in vivo 
adipogenesis but also induce de novo adipogenesis in type I collagen scaffold. ASCs are 
adipose tissue-specific progenitor cells and differentiate into adipocytes or vascular 
cells. Type I collagen exists widely in the animal body and exhibits good 
biocompatibility, gelatification, and structural stability. Hence, type I collagen is a 
superior material for use in regenerative medicine [3, 4] [5]. FGF2 enhances 
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adipogenesis [6, 7]. However, FGF2 is not readily available for breast cancer patients; 
furthermore, a large size of adipose tissue is needed for a long period. In addition, 
some diagnostic modalities are needed during follow up of the implant. The aim of this 
study is to regenerate large amounts of adipose tissue without FGF2 and to maintain 
for a long period. Another aim of this study is to evaluate the usefulness of USG as a 
diagnostic modality. 
 
Materials and methods 
Materials 
A polypropylene (PP) mesh was purchased from FLON Industry Inc. (Tokyo, Japan). 
We prepared a column cage made of PP mesh with a pore size of 200 µm and 5-0 
prolene strings (Ethicon Inc, New Brunswick, NJ, USA). The radius of the cage was 10 
mm, and the height was 10 mm. PELNAC, which is approved for artificial dermis, 
consisting of an atelocollagen sponge layer and a silicone layer was kindly supplied by 
Gunze Co Ltd (Kyoto, Japan). The sheet was 82 x 60 mm in size. First, the silicone layer 
of PELNAC was removed. Then, the type I collagen layer was minced, and suspended 






All the animal experiments were reviewed by the Committee on the Ethics of Animal 
Experiments (Faculty of Medicine, Kyoto University, Kyoto, Japan), and were performed 
in accordance with the Guidelines for Animal Experiments of the Faculty of Medicine, 
Kyoto University.  
Female New Zealand white rabbits (2.5-3.0 kg; Shimizu Laboratory Supply, Kyoto, 
Japan) were used. General anesthesia was applied with an intramuscular injection of 
midazolam (4 mg/kg), medetomidine hydrochloride (0.16 mg/kg), and butorphanol 
tartrate (0.4 mg/kg). A PP cage was implanted into New Zealand white rabbit’s bilateral 
fat pad, and the suspended type I collagen sponge was injected into the cage with 16G 
intravenous cannula. Finally, the skin was closed with a buried suture. The implant was 
harvested 3, 6, and 12 months after implantation, and every specimen was assessed 
with hematoxylin-eosin (H-E) stain. Every experimental group consisted of 4 specimens. 
Percentage of regenerated adipose tissue area within a cage was calculated with NIH 





HITACHI MyLab25 (Hitachi medical corporation, Tokyo, Japan) was used, and 
ultrasonography (USG) was performed under general anesthesia at 1 week, 1 month, 3 
months, 6 months, and 12 months after implantation.  
 
Statistical analysis 
  Statistical differences were determined with a Wilcoxon test. A statistical significance 
was assigned as *p<0.05. JMP version 9 software (SAS Institute Inc., Cary, NC, USA) was 




The ultrasonographic findings are shown in Figure 2. An aechoic area and internal 
hyperechoic mass were noted inside the cage at 1 week (Fig 1A) and 1 month after 
implantation (Fig 1B). A homogenous high echo area was detected inside the cage after 
3 months until 12 months (Fig 1 C, D, and E). 
 
Cross section observation 
Figure 1F and 1G show the gross sections at 3 and 6 months after implantation. At 3 
9 
 
months after implantation, the appearance of the inner side the cage showed high 
water content (Fig 1F). At 6 months after the implantation, the appearance of the inner 




Figure 1 shows H-E staining of the specimen. At 3 months after implantation, type I 
collagen scaffold was observed mainly inside the cage under low magnification (Fig 1I). 
Under high magnification, several vacuoles were found mainly at the margins of the 
cage (Fig 1L). These vacuoles were morphologically adipocytes. Further, many nuclei 
were seen among the scaffold. At 6 months, adipose tissue occupied a large part of the 
cross-section surface under low magnification (Fig 1J). Under high magnification, large 
amount of mature adipocytes were observed and angiogenesis was noted (Fig 1M). At 
12 months, mature adipose tissue was observed mostly inside the cage (Fig.1K). 
Complete regeneration of the adipose tissue was achieved inside the cage (Fig 1N). 
 
Percentage of regenerated adipose tissue area 
  Average percentages of regenerated adipose tissue area within a cage were 31.7 ± 
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10.3, 76.2 ± 13.0, and 92.8 ± 6.6% at 3, 6, and 12 months after implantation, 
respectively (Figure 2). Regenerated adipose tissue area at 6 and 12 months were 
significantly increased compared to at 3month after implantation (p=0.03). 
 
Discussion 
Tissue engineering requires a cell source, a scaffold, and growth factors [8]. In line 
with these requirements, we previously confirmed adipogenesis in mice by implanting 
ASCs with type I collagen scaffold with a controlled- release of FGF2 [2]. Further, we 
confirmed in situ adipogenesis in rabbits by implanting type I collagen with the 
controlled- release of FGF2. Repeated administration of the mixture of collagen 
scaffold and gelatin microspheres containing FGF2 enabled significantly higher area  
at 3months after implantation than that of the single administration of each 
component [9]. In this study, implanting type I collagen inside the cage without ASCs 
and controlled- release of FGF2 resulted in adipogenesis. And an average percentage of 
regenerated adipose tissue within the cage was 92.8 ± 6.6% at 12 months after 
implantation. Type I collagen sponge implanted into the PP cage recruited adequate 
cell source and necessary growth factors. Fibroblast growth factor 2 is a potent 
angiogenic factor, known to be effective for adipogenesis [6, 7]. However, FGF2 cannot 
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be clinically used for treating malignant diseases, because FGF2 has a potency of breast 
carcinogenesis [10]. Our method of adipose tissue engineering without FGF2 is a 
promising way to use FGF2 for clinical purposes. 
Some mechanisms of adipogenesis have been reported. First, type I collagen sponge 
is known to be superior scaffold for ASC adhesion because of its porous structure [5] 
[7]. Generally, cells cannot survive in the absence of adhesive materials. So, the 
observation in this study that lots of nuclei with recruited cells were observed in the 
scaffold 3months after implantation suggested that these cells were precursors of 
mature adipocytes and adhered to type I collagen sponge. Collagen degradation is 
essential for cell migration, proliferation, and differentiation. Type I collagen scaffold 
have degraded and mature adipose tissue was generated inside the cage 6 months 
after implantation. Mature adipose tissue still remained 12 months after implantation. 
O’Connor et al reported a higher rate of adipogenic differentiation in vitro with type I 
collagen than with fibronectin [11]. We have confirmed type I collagen was excellent 
scaffold for adipogenesis in vivo. Secondly, the fat pad was an excellent implantation 
site for adipogenesis. Because the fat tissue in this study was healthy, optimal 
conditions for adipogenesis were satisfied. ASCs are present in the adipose tissue and 
are derived from the surrounding tissue. For example, administration of cell source or 
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growth factors might be required for efficient adipogenesis when the fat tissue have 
received radiation therapy. Third, the growth factors required for adipogenesis were 
produced after implantation. Several growth factors are produced at the operation site 
after surgery. Soluble FGF2, vascular endothelial growth factor (VEGF), platelet derived 
growth factor (PDGF), epidermal growth factor, or insulin-like growth factor-1 (IGF-1) 
have been detected in the wound drainage fluid [12]. Fibroblast growth factor 2 and 
PDGF promote in vitro ASCs proliferation [13]. Fibroblast growth factor 2 and VEGF are 
potent angiogenic factors. Angiogenesis enables blood supply and oxygen to the 
scaffolds. Blood vessel formation was confirmed since 6 months after implantation in 
this study. Adipose tissue engineering requires in vivo vascularization, and in vivo 
vascularization enhanced the formation of engineered adipose tissue. The growth 
factors emanated after the surgery and contributed to adipogenesis. 
The reconstruction of volume-stable adipose tissue for a long period is a great 
challenge. Although the subcutaneous environment is relatively static, the skin does 
exert a compressive force on any material placed subcutaneously. It might also be 
necessary to maintain some extra spaces in order to accommodate the volume-stable 
adipose tissue [14]. In this study, PP mesh was used to maintain this space and is a 
landmark of the engineered adipose tissue area. Although it is easy to detect PP mesh 
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with USG, its material is unabsorbable and hard for breast reconstruction. Further 
studies will be needed to identify soft and absorbable materials that can be used to 
maintain extra space in order to apply this technique in clinical situations. 
It is important to evaluate the regenerated adipose tissue. We used USG to follow up 
the implant over time. Regenerated tissue can be distinguished from areas with water 
content or empty spaces. USG is usually used for breast examination, because it is easy, 
non-invasive, does not involve radiation-exposure, and is cost-effective as compared to 
computed tomography, mammography, or magnetic resonance imaging. Herein, USG is 
a useful modality to assess engineered adipose tissue. 
 
Conclusion 
We achieved complete regeneration of adipose tissue inside the cage at 12 months 
after implantation only by implanting a type-I collagen sponge inside the space. With 
USG, an aechoic area and internal hyperechoic mass gradually disappeared and were 
replaced with homogenous high echoic area, reflecting adipogenesis. USG is a 
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Fig 1. USG findings 1 week (A), 1 (B), 3 (C), 6 (D), and 12 months (E) after implantation. 
Gross views of the implant 3 (F), 6 (G), 12 months (H) after implantation. H-E staining 
(x4) at 3 (I), 6 (J), and 12 months (K) after implantation. H-E staining (x20) at 3 (L), 6 (M), 
and 12 months (N) after implantation. The scale bars in (L), (M), and (N) indicate 
500µm.  
 
Fig 2. Percentages of regenerated adipose tissue area within a cage at 3, 6 and 12 
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months after implantation. Data are mean ± standard deviation from n=4, statistical 
differences (*p < 0.05). 
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